loading page

The use of extra-corporeal membrane oxygenation post-cardiotomy: the survival benefits
  • Thumbnail
  • Tino Harahwa,
  • Cheryl Yan Ting Chor,
  • Amer HarkyOrcid
Tino Harahwa
St. George University London
Author Profile
Cheryl Yan Ting Chor
St. George University London
Author Profile
Amer Harky
Orcid
Liverpool Heart and Chest Hospital NHS Foundation Trust
Author Profile
Medium

Peer review status:ACCEPTED

18 Apr 2020Submitted to Journal of Cardiac Surgery
18 Apr 2020Submission Checks Completed
18 Apr 2020Assigned to Editor
18 Apr 2020Reviewer(s) Assigned
28 Apr 2020Review(s) Completed, Editorial Evaluation Pending
28 Apr 2020Editorial Decision: Revise Minor
04 May 20201st Revision Received
05 May 2020Assigned to Editor
05 May 2020Submission Checks Completed
05 May 2020Reviewer(s) Assigned
15 May 2020Review(s) Completed, Editorial Evaluation Pending
15 May 2020Editorial Decision: Revise Major
18 May 20202nd Revision Received
19 May 2020Submission Checks Completed
19 May 2020Assigned to Editor
19 May 2020Reviewer(s) Assigned
19 May 2020Review(s) Completed, Editorial Evaluation Pending
19 May 2020Editorial Decision: Accept

Abstract

Extra Corporeal Membrane Oxygenation (ECMO) is a supportive therapy used to provide cardiac support with or without respiratory support in the event of cardiopulmonary failure. The two main types of ECMO are Veno-arterial ECMO (VA-ECMO) and Veno-venous ECMO (VV-ECMO). The use of ECMO in cardiac surgery has been established in cases of post-cardiotomy cardiogenic shock which is refractory to conventional therapy with inotropes and intra-aortic balloon pulsation support. Survival for this, otherwise, fatal condition has been shown to be improving through the use of ECMO. However, the decision and timing to initiate ECMO therapy remains selective and is dependent on a range of factors such as patient factor, clinician’s judgement, meaning there is no consistent and solid ground regarding the timing of ECMO initiation. This article will provide an extensive review of ECMO indications, contraindications, complications and outcomes to analyse the survival benefit of ECMO following cardiac surgery.